Santa Ana, CA
NKMax America is harnessing the power of the body's immune system through the development of unique Natural Killer (NK) cell therapies. NK cell adoptive immunotherapy enhances a patient's ability to destroy abnormal cells. The mission of NKMax is to improve patients' lives in a safe and natural way through innovative cell therapy products and to ultimately become the global leader in immune cell therapeutics. More information can be found on our website www.nkmaxamerica.com
nkmaxamerica.comThese are collections NKMax America is a part of. Click on the collection name to view similar companies.
Post Ipo Equity
$2,000,000
Post Ipo Equity
$2,650,000
Post Ipo Debt
$5,000,000
IPO
Unknown
Seed
$11,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on NKMax America.